BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. ✅
Go to Publication ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52 Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y , |
|
|
Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. ✅
Go to Publication ✅
Microbiology and immunology (Microbiol Immunol ) Vol: 59 Issue 11 Pages: 643-52 Pub: 2015 Nov Epub: Authors Shimizu H , Benno Y , |
|
|
Additional sources and private correspondance ✅
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
|
|
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32 Pub: 2006 Jun Epub: Authors Hütt P , Shchepetova J , Lõivukene K , Kullisaar T , Mikelsaar M , |
|
|
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32 Pub: 2006 Jun Epub: Authors Hütt P , Shchepetova J , Lõivukene K , Kullisaar T , Mikelsaar M , |
|
|
Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure. ✅
mSphere (mSphere ) Vol: 5 Issue 1 Pages: Pub: 2020 Jan 29 Epub: 2020 Jan 29 Authors Wang K , Lv L , Yan R , Wang Q , Jiang H , Wu W , Li Y , Ye J , Wu J , Yang L , Bian X , Jiang X , Lu Y , Xie J , Wang Q , Shen J , Li L , |
|
|
Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 289 Issue Pages: 120243 Pub: 2022 Jan 15 Epub: 2021 Dec 16 Authors Quintanilha MF , Miranda VC , Souza RO , Gallotti B , Cruz C , Santos EA , Alvarez-Leite JI , Jesus LCL , Azevedo V , Trindade LM , Cardoso VN , Ferreira E , Carvalho BA , Soares PMG , Vieira AT , Nicoli JR , Martins FS , |
|
|
Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 289 Issue Pages: 120243 Pub: 2022 Jan 15 Epub: 2021 Dec 16 Authors Quintanilha MF , Miranda VC , Souza RO , Gallotti B , Cruz C , Santos EA , Alvarez-Leite JI , Jesus LCL , Azevedo V , Trindade LM , Cardoso VN , Ferreira E , Carvalho BA , Soares PMG , Vieira AT , Nicoli JR , Martins FS , |
|
|
Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 6 Pages: Pub: 2023 Mar 21 Epub: 2023 Mar 21 Authors De Oliveira FL , Salgaço MK , de Oliveira MT , Mesa V , Sartoratto A , Peregrino AM , Ramos WS , Sivieri K , |
|
|
Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 13 Epub: 2024 Apr 13 Authors Liu D , Li C , Cao T , Lv X , Yue Y , Li S , Cheng Y , Liu F , Huo G , Li B , |
|
|
Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 13 Epub: 2024 Apr 13 Authors Liu D , Li C , Cao T , Lv X , Yue Y , Li S , Cheng Y , Liu F , Huo G , Li B , |
|
|
Heat-killed Bifidobacterium longum BBMN68 and inulin protect against high-fat diet-induced obesity by modulating gut microbiota. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 11 Issue Pages: 1406070 Pub: 2024 Epub: 2024 Aug 14 Authors Sun S , Zhang Q , Li D , Li H , Ma H , Wu X , Li Y , Wang P , Liu R , Feng H , Zhang Y , Sang Y , Fang B , Wang R , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD). ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 May 9 Epub: 2024 May 9 Authors Yang L , Wu Y , Zhao X , Liang T , Li L , Yang J , Jiang T , Zhang T , Zhang J , Zhong H , Xie X , Wu Q , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis. ✅
Go to Publication ✅
BMC microbiology (BMC Microbiol ) Vol: 24 Issue 1 Pages: 8 Pub: 2024 Jan 3 Epub: 2024 Jan 3 Authors Yue F , Zeng X , Wang Y , Fang Y , Yue M , Zhao X , Zhu R , Zeng Q , Wei J , Chen T , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium longum Administration Diminishes Parasitemia and Inflammation During Plasmodium berghei Infection in Mice. ✅
Go to Publication ✅
Journal of inflammation research (J Inflamm Res ) Vol: 16 Issue Pages: 1393-1404 Pub: 2023 Epub: 2023 Mar 27 Authors Fitri LE , Sardjono TW , Winaris N , Pawestri AR , Endharti AT , Norahmawati E , Handayani D , Kurniawan SN , Azizah S , Alifia LI , Asiyah R , Ayuningtyas TR , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis. ✅
Go to Publication ✅
Molecular carcinogenesis (Mol Carcinog ) Vol: 61 Issue 10 Pages: 941-957 Pub: 2022 Oct Epub: 2022 Jul 20 Authors Kumar R , Maurya AK , Parker KD , Kant R , Ibrahim H , Kabir MI , Kumar D , Weber AM , Agarwal R , Kuhn KA , Ryan EP , Raina K , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 10 Issue 3 Pages: 1595-1608 Pub: 2019 Mar 20 Epub: Authors Yan S , Yang B , Zhao J , Zhao J , Stanton C , Ross RP , Zhang H , Chen W , |
|
|
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 10 Issue 3 Pages: 1595-1608 Pub: 2019 Mar 20 Epub: Authors Yan S , Yang B , Zhao J , Zhao J , Stanton C , Ross RP , Zhang H , Chen W , |
|
|
The Impact of Fermented Milk Products Containing Bifidobacterium longum BB536 on the Gut Environment: A Randomized Double-Blind Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 21 Pages: Pub: 2024 Oct 22 Epub: 2024 Oct 22 Authors Ejima R , Mishima R , Sen A , Yamaguchi K , Mitsuyama E , Kaneko H , Kimura M , Arai S , Muto N , Hiraku A , Kato K , Kuwano Y , Maruyama H , Nakamura M , Iwabuchi N , Nakano M , Odamaki T , Tanaka M , |
|
|
The Impact of Fermented Milk Products Containing Bifidobacterium longum BB536 on the Gut Environment: A Randomized Double-Blind Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 21 Pages: Pub: 2024 Oct 22 Epub: 2024 Oct 22 Authors Ejima R , Mishima R , Sen A , Yamaguchi K , Mitsuyama E , Kaneko H , Kimura M , Arai S , Muto N , Hiraku A , Kato K , Kuwano Y , Maruyama H , Nakamura M , Iwabuchi N , Nakano M , Odamaki T , Tanaka M , |
|
|
Bifidobacterium longum Subsp. infantis Promotes IgA Level of Growing Mice in a Strain-Specific and Intestinal Niche-Dependent Manner. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 12 Epub: 2024 Apr 12 Authors Ding M , Li B , Chen H , Ross RP , Stanton C , Zhao J , Chen W , Yang B , |
|
|
Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 80 Issue 11 Pages: 341 Pub: 2023 Sep 15 Epub: 2023 Sep 15 Authors Gong Y , Zhong H , Wang J , Wang X , Huang L , Zou Y , Qin H , Yang R , |
|
|
Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 80 Issue 11 Pages: 341 Pub: 2023 Sep 15 Epub: 2023 Sep 15 Authors Gong Y , Zhong H , Wang J , Wang X , Huang L , Zou Y , Qin H , Yang R , |
|
|
Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 80 Issue 11 Pages: 341 Pub: 2023 Sep 15 Epub: 2023 Sep 15 Authors Gong Y , Zhong H , Wang J , Wang X , Huang L , Zou Y , Qin H , Yang R , |
|
|
Cocktails of probiotics pre-adapted to multiple stress factors are more robust under simulated gastrointestinal conditions than their parental counterparts and exhibit enhanced antagonistic capabilities against Escherichia coli and Staphylococcus aureus. ✅
Go to Publication ✅
Gut pathogens (Gut Pathog ) Vol: 7 Issue Pages: 5 Pub: 2015 Epub: 2015 Feb 26 Authors Mathipa MG , Thantsha MS , |
|
|
Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in Mice. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 4 Issue 2 Pages: 78-89 Pub: 2012 Jun Epub: 2012 Feb 25 Authors Lazarenko L , Babenko L , Sichel LS , Pidgorskyi V , Mokrozub V , Voronkova O , Spivak M , |
|
|
Oral supplementation of Bifidobacterium longum strain BR-108 alters cecal microbiota by stimulating gut immune system in mice irrespectively of viability. ✅
Go to Publication ✅
Bioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem ) Vol: 82 Issue 7 Pages: 1180-1187 Pub: 2018 Jul Epub: 2018 Mar 20 Authors Makioka Y , Tsukahara T , Ijichi T , Inoue R , |
|
|
Oral supplementation of Bifidobacterium longum strain BR-108 alters cecal microbiota by stimulating gut immune system in mice irrespectively of viability. ✅
Go to Publication ✅
Bioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem ) Vol: 82 Issue 7 Pages: 1180-1187 Pub: 2018 Jul Epub: 2018 Mar 20 Authors Makioka Y , Tsukahara T , Ijichi T , Inoue R , |
|
|
A proteomic approach towards understanding the cross talk between Bacteroides fragilis and Bifidobacterium longum in coculture. ✅
Go to Publication ✅
Canadian journal of microbiology (Can J Microbiol ) Vol: 62 Issue 7 Pages: 623-8 Pub: 2016 Jul Epub: 2016 Mar 4 Authors Rios-Covián D , Sánchez B , Martínez N , Cuesta I , Hernández-Barranco AM , de Los Reyes-Gavilán CG , Gueimonde M , |
|
|
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 30 Epub: 2024 Nov 30 Authors Lungaro L , Malfa P , Manza F , Costanzini A , Valentini G , Squarzanti DF , Viciani E , Velichevskaya A , Castagnetti A , Barbalinardo M , Gentili D , Cariani A , Ghisellini S , Caputo F , De Giorgio R , Caio G , |
|
|
Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 22 Pages: Pub: 2024 Nov 19 Epub: 2024 Nov 19 Authors Naghibi M , Pont-Beltran A , Lamelas A , Llobregat L , Martinez-Blanch JF , Rojas A , Álvarez B , López Plaza B , Arcos Castellanos L , Chenoll E , Vijayakumar V , Day R , |
|
|
Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 22 Pages: Pub: 2024 Nov 19 Epub: 2024 Nov 19 Authors Naghibi M , Pont-Beltran A , Lamelas A , Llobregat L , Martinez-Blanch JF , Rojas A , Álvarez B , López Plaza B , Arcos Castellanos L , Chenoll E , Vijayakumar V , Day R , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Bifidobacterium longumBL-19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 12 Issue 9 Pages: 6442-6460 Pub: 2024 Sep Epub: 2024 Jun 18 Authors Zhang X , Xu J , Dong X , Tang J , Xie Y , Yang J , Zou L , Wu L , Fan J , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
